Paroxysmal Nocturnal Hemoglobinuria study: MY008211A tablets
Official title Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
ClinicalTrials.gov ID: NCT06933914
What this study is testing
What is MY008211A tablets?
This is an investigational pill being studied as a potential treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH).
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to check if the medicine is safe to take over a long time and to keep providing it to patients who finished earlier trials.
- Who it's for
- People with Paroxysmal Nocturnal Hemoglobinuria (PNH) who have already taken part in earlier studies of this medicine.
- What's involved
- Participants will take the study tablet and visit the clinic for regular check-ups and tests to monitor their health.
- Time commitment
- The study lasts for a long period, requiring regular visits to the clinic.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients who have previously received and completed MY008211A study treatment, and are judged by the investigator to have treatment benefit and may...
- Prior vaccinations against Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae infections.
You likely can't join if
- History of recurrent invasive infections caused by encapsulated organisms, e.g. meningococcus or pneumococcus.
- Known or suspected hereditary complement deficiency.
- Any comorbidity or medical condition (including but not limited to any active systemic bacterial, viral or fungal infection or malignancy) that, in...
The study team makes the final eligibility decision.
Where it is enrolling
- Tianjin, Tianjin Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tianjin, Tianjin Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.